Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced...

Vittorio Sebastiano, co-founder of Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, will present at the prestigious...

ProChile and nine companies will represent the country, which will have its own panel called "Tech Talent: A global perspective from Chile." MIAMI, April 17, 2023 /PRNewswire/ -- For the third...

The "Understanding China – BGA Dialogue" Forum is slated to take place in Guangzhou from April 18 to 20, 2023. Co-hosted by the Chinese Association for Science and Technology, the China Public...

CRB-601 shows dose-dependent antitumor activity correlating with increased binding to αvβ8 in pre-clinical tumor models CRB-601 enhances anti-PD-1 immunotherapy efficacy and induces long-lasting...